Literature DB >> 4725396

Skin test sensitivity and antigen-induced lymphocyte transformation in uraemia.

O Selroos, A Pasternack, M Virolainen.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4725396      PMCID： PMC1553837     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  6 in total

1.  Prolonged survival of skin homografts in uremic patients.

Authors:  G J DAMMIN; N P COUCH; J E MURRAY
Journal:  Ann N Y Acad Sci       Date:  1957-03-22       Impact factor: 5.691

2.  Correlation of tuberculin skin reaction with in vitro lymphocyte transformation.

Authors:  G R Kerby
Journal:  Am Rev Respir Dis       Date:  1968-05

3.  In vitro reactivity of human lymphocytes in uraemia--a comparison with the impairment of delayed hypersensitivity.

Authors:  H Huber; D Pastner; P Dittrich; H Braunsteiner
Journal:  Clin Exp Immunol       Date:  1969-07       Impact factor: 4.330

4.  Blast transformation in vivo and in vitro in carbamazepin hypersensitivity.

Authors:  M Virolainen
Journal:  Clin Exp Immunol       Date:  1971-09       Impact factor: 4.330

5.  An assessment of the mixed leucocyte reaction in renal failure.

Authors:  M W Elves; M C Israëls; M Collinge
Journal:  Lancet       Date:  1966-03-26       Impact factor: 79.321

6.  Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum.

Authors:  W M Newberry; J P Sanford
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808
  6 in total
  15 in total

1.  [Immune mechanisms in uremia].

Authors:  H Dobbelstein
Journal:  Klin Wochenschr       Date:  1975-05-15

2.  Humoral inhibitors of the immune response in uremia. II. Further characterization of an immunosuppressive factor in uremic serum.

Authors:  J Raskova; A B Morrison; S M Shea; K Raska
Journal:  Am J Pathol       Date:  1979-11       Impact factor: 4.307

Review 3.  The use of vaccines in renal failure.

Authors:  D W Johnson; S J Fleming
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

4.  Cancer and chronic renal failure.

Authors:  G Digenis; A Pierratos; D G Oreopoulos
Journal:  CMAJ       Date:  1986-07-01       Impact factor: 8.262

5.  Impaired in vitro growth of PHA induced T lymphocyte colonies in hemodialyzed renal failure patients.

Authors:  R Ghio; E Haupt; V Pistoia; A Perata; P Minale; M Ratti; P Boccaccio
Journal:  Blut       Date:  1985-03

6.  Immunological monitoring in patients with end-stage renal disease.

Authors:  W C Waltzer; R J Bachvaroff; A P Raisbeck; B Egelandsdal; C Pullis; L Shen; F T Rapaport
Journal:  J Clin Immunol       Date:  1984-09       Impact factor: 8.317

7.  Depressed spontaneous cellular cytotoxicity associated with normal or enhanced antibody-dependent cellular cytotoxicity in patients on chronic haemodialysis.

Authors:  A M Badger; D B Bernard; B A Idelson; S R Cooperband
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

8.  T-lymphocyte number and function and the course of hepatitis B in hemodialysis patients.

Authors:  G C De Gast; B Houwen; G K van der Hem; T H The
Journal:  Infect Immun       Date:  1976-11       Impact factor: 3.441

9.  Cell-mediated immunity in patients on long-term haemodialysis.

Authors:  C A Kauffman; A D Manzler; J P Phair
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

10.  Stimulation of lymphocytes by antigen in microplate cultures; absence of an effect of transfer factor in vitro.

Authors:  T Ahern; C J Sanderson
Journal:  Clin Exp Immunol       Date:  1976-03       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.